Company intelligence / Profile preview

Acellera

Barcelona, Catalonia, Spainacellera.com ↗

Ownership: Private
Employees: ~34
Development stage: Commercial

Overview

Acellera has demonstrated success in accelerating small-molecule drug discovery by combining quantum chemistry with AI/machine learning. Their platforms are used by top pharma and biotech companies worldwide to identify lead candidates rapidly. No direct clinical results are reported since they do not develop their own therapeutics but support others' pipelines

Therapeutic areas: Other
Modalities: Small molecules
Industry: Drug Discovery Services

Partnerships

Psivant Therapeutics (strategic collaboration on computational drug discovery using AI and quantum simulations)Numerous undisclosed partnerships with global pharma/biotech companies

Beyond the preview

Go deeper on Acellera.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acellera.

Explore the full profile